Extracellular vesicle as a next-generation drug delivery platform for rheumatoid arthritis therapy - ScienceDirect.com
  Rheumatoid arthritis drug shows promise for treating excessive inflammation due to COVID-19 - Medical Xpress
  Cullinan Therapeutics receives EMA approval for rheumatoid arthritis drug trial - Clinical Trials Arena
  Do Seniors Stop Rheumatoid Arthritis Drugs Due to Cost? - Arthritis Foundation
  In Rheumatoid Arthritis, Precision Medicine Remains "Moonshot" Goal - AJMC
  Drug compound shows promise against rheumatoid arthritis - WashU Medicine
  Multiscale, mechanistic model of Rheumatoid Arthritis to enable decision making in late stage drug development - Nature
  Locally administered liposomal drug depot enhances rheumatoid arthritis treatment by inhibiting inflammation and promoting cartilage repair - Journal of Nanobiotechnology